| 发明名称 |
USE OF SARCOPLASMIC CA2+-ATPASE TYPE 2 PROTEIN FOR DIAGNOSING AND TREATING LEARNING OR MENTAL DISORDERS |
| 摘要 |
<p>The present invention embraces methods for the diagnosis and treatment of learning or mental disorders, as well as the identification of agents useful in the treatment of such disorders based upon the identified involvement of Sarcoplasmic Ca2+-ATPase type 2 Protein in synaptic plasticity and neurotransmitter release in 22qll deletion/DiGeorge Syndrome.</p> |
| 申请公布号 |
WO2011066132(A1) |
申请公布日期 |
2011.06.03 |
| 申请号 |
WO2010US56778 |
申请日期 |
2010.11.16 |
| 申请人 |
ST. JUDE CHILDREN'S RESEARCH HOSPITAL;ZAKHARENKO, STANISLAV, S. |
发明人 |
ZAKHARENKO, STANISLAV, S. |
| 分类号 |
C12Q1/68;A01N43/08;A01N43/38;G01N33/53 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
